<DOC>
	<DOC>NCT01551251</DOC>
	<brief_summary>The purpose of this study is to investigate the effects of tumor associated macrophage (TAM) in advanced non-small cell lung cancer (NSCLC) patients on the treatment response and outcome of these subjects. Pathologic specimens from tissue bank will be stained by immunostaining methods with CD68 antibody. The clinical treatment response and outcomes will be analyzed between high or low TAM.</brief_summary>
	<brief_title>Tumor Associated Macrophage in Advanced Non-small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<criteria>advanced NSCLC, more than 20 years old, measurable tumor, response and outcome recorded after the first line treatment. Early stage NSCLC, less than 20 years, pregnancy, unmeasurable NSCLC.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>